“The only thing she practices is grift”: Meet Trump’s nominee for Surgeon General
Medical experts fear President Donald Trump’s nominee for surgeon general, Casey Means, could bring her “flaky” brand of wellness influencing to the nation. Means is best known as a wellness influencer, author and entrepreneur, as well as running a company that sells glucose monitoring systems. While Means did attend medical school, she dropped out during […]
Ozempic, Wegovy Might Lower Colon Cancer Risk
WEDNESDAY, Jan. 7, 2026 — Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.People who took a GLP-1 drug were 36% less likely to get colon cancer than people who took a…
Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases
Nature Communications, Published online: 07 January 2026; doi:10.1038/s41467-025-67701-9 This umbrella review synthesizes the evidence for safety and efficacy GLP-1 receptor agonists on multiple outcomes including but not limited to metabolic, cardiovascular and renal outcomes.
One food that could help you prevent weight regain
Long-term studies of GLP-1 drugs show that once people stop taking them, they regain more than half of the weight they lost
The affordable food that triggers the body’s own GLP-1
Post Content
How eggs can help you come off Wegovy – cracking the problem of weight-regain – The Conversation
How eggs can help you come off Wegovy – cracking the problem of weight-regain The Conversation How GLP1 drugs work on body and brain against obesity 6abc Philadelphia I Stopped Ozempic and Mounjaro Due to the Cost. thekit.ca Should I consider taking a GLP-1 medication for weight loss? Bethesda Magazine Q&A: How can new drugs help weight loss resolutions […]
Mindy Kaling looks unrecognizable flaunting 40lb weight loss in black cut-out gown at Golden Eve event
The 46-year-old Running Point co-creator has never admitted to taking a trendy GLP-1 agonist drug like Ozempic
From injectables to pills: how the new Wegovy tablet will change the weight loss market forever
The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky looks at how the landscape is changing
Obesity rings in New Year with Lilly-Nimbus $1.3B deal, RNAi data
Biopharma industry zeal for obesity therapeutics does not appear to be dying down any time soon, with Eli Lilly and Co. entering a $1.3 billion deal with Nimbus Therapeutics LLC for a new small molecule, and Arrowhead Pharmaceuticals Inc. rolling out phase I/IIa data of its RNAi therapeutics used in combination with Lilly’s GLP-1/GIP receptor […]
GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
(MedPage Today) — SAN FRANCISCO — Patients with a history of GLP-1 receptor agonist treatment had a significantly lower risk of developing colorectal cancer (CRC) as compared with those who took aspirin, according to a retrospective study reported…